Guardant Health, Inc.
GH
$35.84
-$3.48-8.85%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 30.16% | 33.87% | 29.23% | 30.90% | 22.19% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 30.16% | 33.87% | 29.23% | 30.90% | 22.19% |
| Cost of Revenue | 24.12% | 29.29% | 34.49% | 23.03% | 32.67% |
| Gross Profit | 34.24% | 36.96% | 25.82% | 36.43% | 16.00% |
| SG&A Expenses | 34.51% | 39.83% | 8.71% | 2.15% | -5.25% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 21.95% | 20.33% | 8.23% | 2.06% | -1.93% |
| Operating Income | -10.83% | -3.23% | 15.92% | 25.64% | 22.65% |
| Income Before Tax | 41.21% | -25.83% | -41.81% | 14.04% | -34.63% |
| Income Tax Expenses | 232.35% | -93.88% | -73.19% | 68.75% | -189.87% |
| Earnings from Continuing Operations | 40.65% | -25.15% | -41.03% | 13.89% | -33.67% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 40.65% | -25.15% | -41.03% | 13.89% | -33.67% |
| EBIT | -10.83% | -3.23% | 15.92% | 25.64% | 22.65% |
| EBITDA | -12.37% | -4.01% | 17.46% | 28.08% | 24.83% |
| EPS Basic | 43.17% | -19.75% | -25.31% | 27.37% | -15.63% |
| Normalized Basic EPS | -9.48% | 0.39% | 6.93% | 45.87% | 41.17% |
| EPS Diluted | 43.17% | -19.75% | -25.31% | 27.37% | -15.63% |
| Normalized Diluted EPS | -9.48% | 0.39% | 6.93% | 45.87% | 41.17% |
| Average Basic Shares Outstanding | 4.43% | 4.51% | 12.53% | 18.55% | 15.60% |
| Average Diluted Shares Outstanding | 4.43% | 4.51% | 12.53% | 18.55% | 15.60% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
